OPN1SW and breast carcinoma: Additionally, in breast cancer MDA-MB-468 cells, BCP activated checkpoint that enhanced the induction of G2/M phase arrest, and thus promoted cell death [13], which agrees with what has been obtained in doxorubicin treated cholangiocarcinoma cells (CCAs) supplemented with BCP [46].